scholarly article | Q13442814 |
P50 | author | Jun-ichi Iga | Q48949274 |
Ryo Okubo | Q86205160 | ||
P2093 | author name string | Hiroto Ito | |
Norihiro Sato | |||
Koichi Ito | |||
Yasuhiro Matsuda | |||
Minoru Honda | |||
Ichiro Kusumi | |||
Naoki Hashimoto | |||
Yoichi M Ito | |||
Keiichi Uemura | |||
Jun Yamada | |||
Yoshiteru Takekita | |||
Nobuyuki Mitsui | |||
Yuki Kako | |||
Bunta Yoshimura | |||
Yuki Arai | |||
Akiko Konishi | |||
Nobuyuki Nishi | |||
Hiroyoshi Yamanaka | |||
Kaoru Shinohara | |||
Takayuki Segawa | |||
Kiyoshi Tsuchiya | |||
Akihiko Tochigi | |||
Shinsaku Inomata | |||
Noriko Tsukamoto | |||
Yasufumi Sugawara | |||
Yukihiko Matsuda | |||
Ikuta Shinkawa | |||
Sigehiro Matsubara | |||
P2860 | cites work | Impaired fasting glucose, blood pressure and cardiovascular disease mortality | Q44167916 |
Screening for diabetes and other metabolic abnormalities in patients with schizophrenia and schizoaffective disorder: evaluation of incidence and screening methods. | Q50792652 | ||
Predictive value of prehypertension for metabolic syndrome, diabetes, and coronary heart disease among Turks. | Q51118122 | ||
Progression from optimal blood glucose and pre-diabetes to type 2 diabetes in a high risk population with or without hypertension in Isfahan, Iran. | Q51305749 | ||
Screening for diabetes using monitoring guidance in schizophrenia patients treated with second-generation antipsychotics: a 1-year follow-up study. | Q51370027 | ||
Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. | Q51557409 | ||
Planning for the optimal design of studies to personalize antipsychotic prescriptions in the post-CATIE era: the clinical and pharmacoepidemiological data suggest that pursuing the pharmacogenetics of metabolic syndrome complications (hypertension, | Q80584011 | ||
Consensus development conference on antipsychotic drugs and obesity and diabetes | Q94355363 | ||
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies | Q24608301 | ||
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis | Q28303010 | ||
Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1 | Q31145823 | ||
Screening for diabetes using Japanese monitoring guidance in schizophrenia patients treated with second-generation antipsychotics: a cross-sectional study using baseline data | Q33890480 | ||
Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries | Q34796516 | ||
Diabetes and hypertension: is there a common metabolic pathway? | Q35857205 | ||
Abnormalities of glucose metabolism associated with atypical antipsychotic drugs | Q35985098 | ||
Metabolic monitoring for patients treated with antipsychotic medications | Q36577861 | ||
Early treatment-related changes in diabetes and cardiovascular disease risk markers in first episode psychosis subjects | Q36744444 | ||
Postmortem analysis of cardiovascular deaths in schizophrenia: a 10-year review | Q38136732 | ||
Sudden unexpected death in schizophrenia: autopsy findings in psychiatric inpatients | Q38202393 | ||
The prevalence and predictors of type two diabetes mellitus in people with schizophrenia: a systematic review and comparative meta-analysis | Q38460789 | ||
Prevalence and predictors of type 2 diabetes mellitus in people with bipolar disorder: a systematic review and meta-analysis | Q38555006 | ||
Insulin resistance and hypertension in Japanese | Q41548287 | ||
Prevalence of diabetes and antipsychotic prescription patterns in patients with schizophrenia: a nationwide retrospective cohort study | Q42653611 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | schizophrenia | Q41112 |
bipolar disorder | Q131755 | ||
hyperglycemia | Q271993 | ||
P304 | page(s) | 454-460 | |
P577 | publication date | 2018-10-30 | |
P1433 | published in | BJPsych open | Q27726839 |
P1476 | title | Predictive factors for hyperglycaemic progression in patients with schizophrenia or bipolar disorder | |
P478 | volume | 4 |
Search more.